pentobarbital will minimize the extent or outcome of hydrocortisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
Insignificant (one)pentobarbital will lessen the extent or influence of paclitaxel protein bound by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unfamiliar.
pentobarbital will minimize the extent or result of buprenorphine subdermal implant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Keep an eye on people presently on buprenorphine subdermal implant who demand freshly-initiated treatment method with CYP3A4 inducer for indicators and signs and symptoms of withdrawal.
pentobarbital will decrease the extent or influence of ramelteon by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Mysterious.
pentobarbital will decrease the level or outcome of repaglinide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lessen the level or effect of flurbiprofen by affecting hepatic enzyme CYP2C9/ten metabolism. Slight/Importance Unfamiliar.
Monitor Closely (one)pentobarbital will lessen the level or outcome of exemestane by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. For sufferers getting exemestane using a powerful CYP3A4 inducer the advisable dose of exemestane is fifty mg daily following a food.
pentobarbital will lower the level or effect of fostemsavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Contraindicated (one)pentobarbital will decrease the extent or result of fostemsavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the extent or outcome of vincristine liposomal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unfamiliar.
pentobarbital will decrease the extent or impact of ondansetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. No dosage adjustment for ondansetron is suggested for individuals on these drugs.
pentobarbital will lessen the extent or outcome of vincristine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unidentified.
Reserve concomitant prescribing of those medications in patients for whom other therapy alternatives are inadequate. Restrict dosages and website durations into the minimum amount demanded. Observe carefully for signs of respiratory depression and sedation.
pentobarbital will reduce the level or outcome of voriconazole by influencing hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Mysterious.